Format

Send to

Choose Destination
Qual Life Res. 2016 Jan;25(1):81-8. doi: 10.1007/s11136-015-1071-y. Epub 2015 Aug 12.

Development and validation of a carers quality-of-life questionnaire for parkinsonism (PQoL Carers).

Author information

1
Faculty of Social and Human Sciences, University of Southampton, Southampton, UK.
2
Department of Clinical Neurosciences, UCL Institute of Neurology, University College London, London, UK.
3
Movement Disorder Program, Department of Neurology, University of Louisville, Louisville, KY, USA.
4
Toronto Western Hospital and the University of Toronto, Toronto, ON, Canada.
5
Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN, USA.
6
Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne, UK.
7
Department of Clinical Neurosciences, UCL Institute of Neurology, University College London, London, UK. a.schrag@ucl.ac.uk.

Abstract

PURPOSE:

Atypical parkinsonism (AP) has a considerable impact on the lives not only of patients but also of their carers. The aim of this study was to develop an instrument for assessing the quality of life (QoL) of carers of patients with AP.

METHODS:

A 40-item pool was generated from in-depth interviews with carers of patients with AP, a thorough review of the existing literature and consultation with movement disorder experts. Item refinement and reduction was performed using the results of pilot testing and a survey in 282 carers of multiple system atrophy (MSA) patients and 226 carers of progressive supranuclear palsy (PSP) patients. A validation study, with responses of 243 carers of MSA and 187 carers of PSP patients, was undertaken to evaluate the psychometric properties of the final 26-item scale.

RESULTS:

The validation study results suggest that the scale is unidimensional and has high internal consistency (Cronbach's α = 0.96). The correlations of scale scores with patients' health status and QoL measures, such as PDQ-39 summary score and EQ-5D index (Spearman's ρ = 0.56 and -0.31, respectively, P < 0.001), as well as carers' measures, such as Caregiver Burden Inventory (CBI) total and EQ-5D index (Spearman's ρ = 0.85 and -0.39, respectively, P < 0.001), document the convergent and concurrent validity of the scale. ANOVA results support the discriminant validity of the scale, as evidenced by its capacity to differentiate between carers with varying levels of self-reported health.

CONCLUSIONS:

The 26-item Parkinsonism Carers QoL (PQoL Carer) is a concise instrument with adequate psychometric qualities that can be used for clinical and research purposes.

KEYWORDS:

Atypical parkinsonism; Instrument validation; Patient carers; Quality of life

PMID:
26264781
DOI:
10.1007/s11136-015-1071-y
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center